| Structure |
Chemical Name |
CAS |
MF |
 |
4-(4-メトキシフェニル)-3-ブテン-2-オン |
943-88-4 |
C11H12O2 |
 |
Dobutamine Impurity 16 |
|
|
 |
Lanthanum test solution(ChP) |
|
|
 |
クロロクリプチン |
68944-88-7 |
C32H40ClN5O5 |
![3,10,11-トリヒドロキシ-6H-ジベンゾ[b,d]オキソシン-7(8H)-オン](/CAS/20180808/GIF/102036-28-2.gif) |
3,10,11-トリヒドロキシ-6H-ジベンゾ[b,d]オキソシン-7(8H)-オン |
102036-28-2 |
C15H12O5 |
 |
ノトギンセノシドFP2 |
1004988-75-3 |
C58H98O26 |
 |
Notoginsenoside FP1 |
1004988-73-1 |
C47H80O18 |
![安息香酸3-[7-シアノ-5-[(2R)-2-[[2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチル]アミノ]プロピル]インドリン-1-イル]プロピル](/CAS/GIF/885340-11-4.gif) |
安息香酸3-[7-シアノ-5-[(2R)-2-[[2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチル]アミノ]プロピル]インドリン-1-イル]プロピル |
885340-11-4 |
C32H34F3N3O4 |
 |
Iguratimod Impurity 9 |
1179354-65-4 |
C18H16N2O6S |
 |
L-Proline, 5-oxo-, compd. with chitosan |
117522-93-7 |
|
 |
(E/Z)-FK-50626,28-アリリックエステル転位不純物 |
131944-48-4 |
C44H69NO12 |
 |
Deiodo Trametinib |
871700-65-1 |
C26H24FN5O4 |
![Acetamide, N-[4-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-](/CAS/20210305/GIF/871701-23-4.gif) |
Acetamide, N-[4-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]- |
871701-23-4 |
C26H23FIN5O4 |
 |
2-(2-Fluoro-4-iodo-aniline)-4-hydroxy-1, 5-dimethyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid cyclopropylamide |
3018911-27-5 |
C17H17FIN3O3 |
![Pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione, 1-(3-aminophenyl)-3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-](/CAS/GIF/871701-87-0.gif) |
Pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione, 1-(3-aminophenyl)-3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl- |
871701-87-0 |
C24H21FIN5O3 |
 |
Baricitinib Impurity 6 |
2166596-69-4 |
C12H19N3O2Si |
 |
17β-(3-シクロペンチルプロピオニルオキシ)エストラ-4-エン-3-オン |
601-63-8 |
C26H38O3 |
![N-[[7-(AMINOSULFONYL)-6-CHLORO-2,3-DIHYDRO-1,1-DIOXO-4H-1,2,4-BENZOTHIADIAZIN-4-YL]METHYL]-6-CHLORO-3,4-DIHYDRO-1,1-DIOXO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDEヒドロクロロチアジ](/CAS/GIF/402824-96-8.gif) |
N-[[7-(AMINOSULFONYL)-6-CHLORO-2,3-DIHYDRO-1,1-DIOXO-4H-1,2,4-BENZOTHIADIAZIN-4-YL]METHYL]-6-CHLORO-3,4-DIHYDRO-1,1-DIOXO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDEヒドロクロロチアジ |
402824-96-8 |
C15H16Cl2N6O8S4 |
 |
アゼチジン-1-スルホンアミド |
654073-32-2 |
C3H8N2O2S |
![4-メチルベンゼンスルホン酸3-シクロプロピル-1-(2-フルオロ-4-ヨードフェニル)-6,8-ジメチル-2,4,7-トリオキソ-1,2,3,4,7,8-ヘキサヒドロピリド[2,3-D]ピリミジン-5-イル](/CAS/GIF/871700-32-2.gif) |
4-メチルベンゼンスルホン酸3-シクロプロピル-1-(2-フルオロ-4-ヨードフェニル)-6,8-ジメチル-2,4,7-トリオキソ-1,2,3,4,7,8-ヘキサヒドロピリド[2,3-D]ピリミジン-5-イル |
871700-32-2 |
C25H21FIN3O6S |
 |
Afatinib Impurity 17 |
1870880-09-3 |
C20H18Cl2FN5O |
 |
4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine |
570407-42-0 |
C17H23ClN4S2 |
 |
T-IRR |
|
|
 |
Avatrapa impurity 12 |
570403-04-2 |
C23H24Cl3N5OS2 |
 |
Afatinib Impurity 14 |
|
|
 |
Baricitinib Impurity 1 |
2964606-44-6 |
C15H15N7O2S |
 |
Afatinib impurity 33 |
|
|
 |
Avatrombopag Impurity 75 |
|
|
![Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)imino]-3,4,5,6,7,8-hexahydro-8-hydroxy-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-](/CAS/20210305/GIF/1383430-03-2.gif) |
Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)imino]-3,4,5,6,7,8-hexahydro-8-hydroxy-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]- |
1383430-03-2 |
C26H23FIN5O5 |
 |
Losartan Impurity 7 |
358685-13-9 |
C33H24Br2N4 |
![6-(4-{2-[3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-2-methyl-heptan-2-ol](/CAS/GIF/140710-96-9.gif) |
6-(4-{2-[3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-2-methyl-heptan-2-ol |
140710-96-9 |
C39H72O3Si2 |
 |
DOXYCYCLINE RELATED COMPOUND A ((4S,4AR,5S,5AR,6S,12AS)-4-(ジメチルアミノ)-1,4,4A,5,5A,6,11,12A-オクタヒドロ-3,5,10,12,12A-ペンタヒドロキシ-6-メチル-1,11-ジオキソ-2-ナフタセンカル |
3219-99-6 |
C22H24N2O8 |
![1-(6-メトキシ-1H-ベンゾ[D]イミダゾール-2-イル)-3,5-ジメチル-4-オキソ-1,4-ジヒドロピリジン-2-カルボン酸](/CAS/20150408/GIF/1227380-90-6.gif) |
1-(6-メトキシ-1H-ベンゾ[D]イミダゾール-2-イル)-3,5-ジメチル-4-オキソ-1,4-ジヒドロピリジン-2-カルボン酸 |
1227380-90-6 |
C16H15N3O4 |
 |
beta-D-Hydroxymethoxymethylanthraquinonyl glucopyranoside |
29013-18-1 |
C22H22O10 |
![4H-Inden-4-one, 1-[1,5-dimethyl-5-[(triethylsilyl)oxy]hexyl]octahydro-7a-methyl-, [1R-[1α(R*),3aβ,7aα]]-](/CAS/20180808/GIF/144848-24-8.gif) |
4H-Inden-4-one, 1-[1,5-dimethyl-5-[(triethylsilyl)oxy]hexyl]octahydro-7a-methyl-, [1R-[1α(R*),3aβ,7aα]]- |
144848-24-8 |
C24H46O2Si |
 |
Miconazole IMpurity H |
181931-30-6 |
C18H16Cl2N2O |
 |
Mouse Neonatal Thyroxine,NN-T4 ELISA Kit |
|
|
![[R,(+)]-2,4-ジヒドロキシ-3,3-ジメチル酪酸ナトリウム](/CAS/GIF/60979-68-2.gif) |
[R,(+)]-2,4-ジヒドロキシ-3,3-ジメチル酪酸ナトリウム |
60979-68-2 |
C{6}H{11}NaO{4} |
 |
Abacavir |
141271-12-7 |
C10H14ClN5O |
 |
Adefovir Impurity 10 |
|
|
 |
N-Dealkyl Flurazepam (Midazolam impurity) |
|
|
 |
ethyl 6-bromo-4,7-bis((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-indole-3-carboxylate |
|
|
![4-Piperidinecarboxylic acid, 1-[5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-3-hydroxy-2-pyridinyl]-](/CAS/20200611/GIF/1290121-42-4.gif) |
4-Piperidinecarboxylic acid, 1-[5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-3-hydroxy-2-pyridinyl]- |
1290121-42-4 |
C29H35ClN6O4S2 |
 |
2-Thiazolamine, 4-(5-bromo-4-chloro-2-thienyl)- |
1534575-19-3 |
C7H4BrClN2S2 |
 |
Avatrombopag Impurity 24 |
|
|
 |
Vancomycin Impurity J |
2416251-24-4 |
C66H75Cl2N9O24 |
 |
2-アミノ-4-(5-クロロチエン-2-イル)チアゾール |
123971-45-9 |
C7H5ClN2S2 |
 |
3-Bromo Carbidopa |
1246819-09-9 |
C10H13BrN2O4 |
 |
Avanafil iMpurity 4 |
874482-97-0 |
C8H11Cl2NO |
 |
Adefovir Impurity 5 |
|
|
 |
Adefovir Dipivoxil Impurity 24 |
116384-58-8 |
C14H23O7PS |
 |
5-hydroxy-N,1,2-trimethyl-1H-indole-3-carboxamide |
|
|
 |
Avatrombopag Impurity 38 |
|
|
 |
Aatrombopag Impurity 17 |
1268118-96-2 |
C7H4BrClN2S2 |
 |
Metabotropic glutamate receptor 5 (GRM5) Antibody |
|
|
 |
Cationic panthenol |
|
|
 |
N4,N7-bis(3-chloro-4-fluorophenyl)-8-nitroquinazoline-4,7-diamine |
|
|
 |
7-(2-デオキシアデノシン-N6-イル)アリストラクタムI |
127191-86-0 |
C27H22N6O7 |
 |
Afatinib Impurity 22 |
|
|
 |
Afatinib impurity 30 |
|
|
 |
2-bromo-1-(4-chlorothiophen-2-yl)ethanone |
677007-73-7 |
C6H4BrClOS |
 |
N-(7-chloro-4-((3-chloro-4-fluorophenyl)amino)quinazolin-6-yl)-4-(dimethylamino)butanamide |
|
|
 |
Afatinib Impurity 18 |
2316847-95-5 |
C22H20ClFN4O4 |
 |
Afatinib Impurity 24 |
|
|
 |
Afatinib impurity 27 |
|
|
 |
Avatrombopag Impurity ABCDEFGHJKL |
|
|
 |
溶剤脱ワックス重質飽和炭化水素石油蒸留物 |
64742-65-0 |
|
 |
Free and total Chlorine, ion specific meter |
|
|
 |
Afatinib Impurity 15 |
|
|
 |
Afatinib impurity 34 |
2475095-50-0 |
C14H7ClF2N4O2 |
 |
Afatinib Impurity I |
|
|
 |
Alvatrombopag Impurity 999 |
|
|
 |
1-(5-フルオロペンチル)-1H-インドール-3-カルボン酸1-ナフチル |
837112-21-7 |
C24H22FNO2 |
 |
Afatinib Impurity 23 |
1314777-66-6 |
C8H4FN3O3 |
 |
Afatinib impurity 31 |
|
|
 |
Afatinib Impurity 10 |
2475095-06-6 |
C48H50Cl2F2N10O6 |
 |
Avatrombopag Impurity 77 |
|
|
 |
N-(4-((3-chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(dimethylamino)butanamide |
|
|
 |
MEGACELL™ ダルベッコ改変イーグル培地 |
|
|
 |
Afatinib Impurity 19 |
1245555-42-3 |
C21H21ClFN5O2 |
 |
Afatinib Impurity 25 |
|
|
 |
Afatinib impurity 28 |
|
|
 |
Afatinib impurity 11/Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib |
2223677-58-3 |
C22H20ClFN4O4 |
 |
(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-hydroxybut-2-enamide |
|
|
 |
N-(3-chloro-4-fluorophenyl)-7-fluoro-6,8-dinitroquinazolin-4-amine |
|
|
 |
5-chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(4-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)piperidin-1-yl)nicotinamide |
2948773-23-5 |
|
 |
HYDROXYZINE HYDROCHLORIDE |
|
C21H28Cl2N2O2 |
 |
Avatrombopag Impurity 59 |
|
|
 |
5-(Propylthio)-1H-benzimidazol-2-amine |
80983-36-4 |
C10H13N3S |
 |
Afatinib Impurity 21 |
2044709-72-8 |
C18H16F2N4O2 |
 |
Afatinib impurity 32 |
|
|
 |
(1-ジアゾ-2-オキソプロピル)ホスホン酸ジメチル |
90965-06-3 |
C5H9N2O4P |
 |
Avatrombopag Impurity 22 |
570403-14-4 |
C31H38Cl2N6O3S2 |
 |
Avatrombopag Impurity 76 |
|
|
 |
(S)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)butanamide |
|
|
 |
Afatinib Impurity 20 |
|
|
 |
2-amino-4-fluoro-5-nitrobenzoic acid |
1194097-41-0 |
C7H5FN2O4 |
 |
Afatinib Impurity 26 |
|
|
 |
Afatinib impurity 29 |
1957132-02-3 |
C22H23ClFN5O2 |
 |
Acrivastine Impurity 1 |
|
|